Amarantus Bioscience Holdings Inc (AMBS)

[joboggi]

"Now these numbers also mean that any BD study on the current patients, even though it is too small in number also cannot be evaluated properly until the people go to autopsy. After following the patients, what you thought you had is not what you are going to wind up with, which is not unexpected."

this is a quote from the last post, It needs a small correction.

The second line should read, even though the upcoming BD study is too small....
_______________
Tying in the Oct 2013 announcement that they validated the Lympro test to the poster number one, you see that they meant the data on healthy subjects validated the use of the test in general.

It was implied that the results posted in October 2013 somehow validated the sensitivity and spec previously reported in the 90's.

That study, is not yet completed, The completed BD study was a validation of the ability of the test to be performed correctly in independent hands.

Good luck to all of you, and see you in 2 weeks, and not before.